DB19127InvestigationalProtein Based Therapies
Radotermin is under investigation in clinical trial NCT01182337 (A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal Rhgdf-5 for the Treatment of Early Stage...
- Also known as
- Growth differentiation factor 5 (human), homodimer · Recombinant human growth and differentiation factor-5
- Code names
- MP52 · rhGDF-5
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Radotermin, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account